List of Prolong Pharmaceuticals patents | 6 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10172949 Hemoglobin compositions	Patent 10172949 was granted and assigned to Prolong Pharmaceuticals on January, 2019 by the United States Patent and Trademark Office.	Prolong Pharmaceuticals	Prolong Pharmaceuticals	United States Patent and Trademark Office	10172949	January 8, 2019
‌ US Patent 8765924 Modified erythropoietin	Patent 8765924 was granted and assigned to Prolong Pharmaceuticals on July, 2014 by the United States Patent and Trademark Office.		Prolong Pharmaceuticals	United States Patent and Trademark Office	8765924	July 1, 2014
‌ US Patent 10772937 Hemoglobin compositions		Prolong Pharmaceuticals	Prolong Pharmaceuticals	United States Patent and Trademark Office	10772937	September 15, 2020
‌ US Patent 10780148 Hemoglobin compositions		Prolong Pharmaceuticals	Prolong Pharmaceuticals	United States Patent and Trademark Office	10780148	September 22, 2020
‌ US Patent 10172950 Hemoglobin compositions	Patent 10172950 was granted and assigned to Prolong Pharmaceuticals on January, 2019 by the United States Patent and Trademark Office.	Prolong Pharmaceuticals	Prolong Pharmaceuticals	United States Patent and Trademark Office	10172950	January 8, 2019
‌ US Patent 10080782 Hemoglobin compositions	Patent 10080782 was granted and assigned to Prolong Pharmaceuticals on September, 2018 by the United States Patent and Trademark Office.		Prolong Pharmaceuticals	United States Patent and Trademark Office	10080782	September 25, 2018